The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
From medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact Areas
Explore stories, news, insights, and data across articles, videos, and podcasts.
view all content types
of all universities in the world*
students
of the student body are Arab Israeli
The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Explore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATSATS is a community of supporters, innovators, and champions of possibility united by one mission: transforming Israel and the world through science and discovery.
Learn MoreFor more than 100 years, the Technion has been Israel's technological engine and leading driver of innovation, technology, and entrepreneurship, transforming ideas into impact.
Learn More
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn MoreFrom medicine to security, explore how the Technion is advancing Israel and improving lives around the world.
View All Impact AreasExplore stories, news, insights, and data across articles, videos, and podcasts.
view all content typesExplore ATS, the Technion, and the people behind the breakthroughs redefining what's possible for Israel and the world.
Learn More About ATS
As executive vice president for research from 2019 to 2023, he made significant progress to boost ties between the Technion and industry. He oversaw the coordination and development of research contracts with funding agencies and industry, new collaborative research agreements, research prizes, and ethics in research. As part of this leadership role, he helmed the Technion’s tech transfer commercialization office, Technion Technology Transfer (T3). He also served as CEO of the Technion R&D Foundation (TRDF), a subsidiary that serves as the administrative and financial framework for research activities, scientific experiments, and technical analyses.
As a mathematician, Prof. Rubinstein focuses on applied math, spanning several disciplines including partial differential equations, asymptotic analysis, hydrodynamics, superconductivity, optics, medicine, and more. He has published more than 120 papers and holds nine international patents. He also co-founded the startup Inray, which developed software for the optometry market and was sold in 2012 to Shamir Optical.
Prof. Rubinstein earned his bachelor’s degree at Tel Aviv University, his master’s degree at the Technion in 1982, and his Ph.D. at the Courant Institute of Mathematical Sciences at New York University in 1985. He conducted postdoctoral research at Stanford University and joined the Technion in 1988, where he chaired the Applied Mathematics Program for three terms between 1995 and 2010, and chaired the Faculty of Mathematics from 2009 to 2012. He has also been president of the Israel Mathematical Union, and currently serves as an adjunct professor in the Mathematics Department at Indiana University, a position he has held since 2007.
Prof. Rubinstein has received a number of awards including the Landau Prize in Exact Science, the New England and the Seiden Awards for scientific excellence, the H. Rich Award for Innovation, the S. Kaplan Award for creative management, and the Member for Life Award from the Technion Students Association. In 2009, he was elected a Fellow of the American Association for the Advancement of Science, now called AAAS.
Pictured Above / (L to R) Professor Meytal Landau, Professor Asya Rolls, Professor Avi Schroeder, Assistant Professor Graham de Ruiter, and Professor Nadav Amdursky Recently, five researchers from the Technion were awarded prestigious Consolidator Grants by the European Research Council (ERC) for unique projects in their respective disciplines. The ERC Consolidator Grants provide $2.14 million to each recipient and are awarded to scientists with 7-12 years of postdoctoral research experience to fund their explorations and allow them to pursue their most promising ideas. The five Technion recipients are: Associate Professor Nadav Amdursky, a researcher in the Schulich Faculty of Chemistry…
Pictured Above / Professor Shai Shen-Orr Building upon an existing, multi-year cooperation agreement that began in 2019, Pfizer Inc. recently invested $20 million in CytoReason, an Israeli startup co-founded by Technion Professor Shai Shen-Orr. The new agreement gives Pfizer the option to license CytoReason’s artificial intelligence (AI) led platform for drug development as well as fund additional research projects for the company. The partnership’s value is estimated to grow to $110 million by 2027. CytoReason’s technology makes data-driven decisions on drug development quickly and cost effectively by collecting data from pharmaceutical companies to simulate human disease and then uses their…
Bringing these diverse fields together under one roof is intended to shorten the journey from discovery to application, creating an environment where medical needs can spark new research and promising innovations can move more quickly toward the patients who need them. “The combination of a research hospital and a technological university provides the entire value […]
Stay on top of the latest breaking scientific discoveries from Israel and the Technion. Subscribe to the ATS newsletter.